Literature DB >> 15970594

Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner.

Weifei Zhu1, Eric J Smart.   

Abstract

Dietary free fatty acids have been reported to have various effects on the endothelium including the generation of nitric oxide. The goal of the current study was to determine the mechanism whereby free fatty acid causes an increase in nitric oxide synthesis. The specific hypothesis tested was that free fatty acid association with CD36, a class B scavenger receptor, induces the activation of endothelial nitric-oxide synthase (eNOS). A human microvascular endothelial cell line and a transfected Chinese hamster ovary cell system were used to determine which free fatty acids stimulate eNOS. Surprisingly, only myristic acid, and to a lesser extent palmitic acid, stimulated eNOS. The stimulation of eNOS was dose- and time-dependent. Competition experiments with other free fatty acids and with a CD36-blocking antibody demonstrated that the effects of myristic acid on eNOS required association with CD36. Further mechanistic studies demonstrated that the effects of myristic acid on eNOS function were not dependent on PI 3-kinase, Akt kinase, or calcium. Pharmacological studies and dominant negative constructs were used to demonstrate that myristic acid/CD36 stimulation of eNOS activity was dependent on the activation of AMP kinase. These data demonstrate an unexpected link among myristic acid, CD36, AMP kinase, and eNOS activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970594     DOI: 10.1074/jbc.M501238200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  CD36 may determine our desire for dietary fats.

Authors:  Nada A Abumrad
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 3.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 4.  Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Gábor Csányi; Patrick J Pagano; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2014-01-11       Impact factor: 11.583

Review 5.  Cellular fatty acid uptake: a pathway under construction.

Authors:  Xiong Su; Nada A Abumrad
Journal:  Trends Endocrinol Metab       Date:  2009-01-29       Impact factor: 12.015

6.  Metabolomic profiling of cellular responses to carvedilol enantiomers in vascular smooth muscle cells.

Authors:  Mingxuan Wang; Jing Bai; Wei Ning Chen; Chi Bun Ching
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

Review 7.  Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; William A Frazier; Murali C Krishna; David A Wink; David D Roberts
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

Review 8.  Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Authors:  J S Isenberg; W A Frazier; D D Roberts
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

9.  Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.

Authors:  Jeff S Isenberg; Yifeng Jia; Julia Fukuyama; Christopher H Switzer; David A Wink; David D Roberts
Journal:  J Biol Chem       Date:  2007-04-05       Impact factor: 5.157

10.  The role of thrombospondins in wound healing, ischemia, and the foreign body reaction.

Authors:  Themis R Kyriakides; Susan Maclauchlan
Journal:  J Cell Commun Signal       Date:  2009-10-21       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.